For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 815,902 | |||
| General and administrative expenses | 1,367,916 | |||
| Share-based compensation | 39,170 | |||
| Total operating expenses | 2,222,988 | |||
| Loss from operations | -2,222,988 | |||
| Financial expense, net | -41,478 | |||
| Change in fair value of derivative | -29,448 | |||
| Convertible promissory note discount amortization | 309,869 | |||
| Total other expenses, net | -321,899 | |||
| Loss before provision for income taxes | -2,544,887 | |||
| Net loss | -2,544,887 | |||
| Basic EPS | 0 | |||
| Diluted EPS | 0 | |||
| Basic Average Shares | 956,997,116 | |||
| Diluted Average Shares | 956,997,116 | |||
Dror Ortho-Design, Inc. (DROR)
Dror Ortho-Design, Inc. (DROR)